Table 2.
Clinical parameters at T0 and T1 in IP and HLCT patients.
| IP | HLCT | Effect size ( r ) | |||||
|---|---|---|---|---|---|---|---|
| T0 | T1 | T0 | T1 | IP vs. HLCT at T0a | IP T0 vs. T1b | HLCT T0 vs. T1b | |
| Weight (kg) | 36.00 [32.50–39.50] | 37.90 [35.10–42.70]* | 39.30 [36.20–41.00] | 41.60 [38.80–43.50]*** | 0.162 | 0.443 | 0.603 |
| Height (cm) | 158.00 [150.00–162.00] | 158.00 [150.00–162.00] | 160.00 [151.00–162.50] | 160.00 [152.00–163.00] | – | – | – |
| pBMI | 0.50 [0.50–5.00] | 3.00 [0.50–9.00] | 2.00 [0.50–6.00] | 10.00 [2.00–28.00]** | 0.116 | 0.242 | 0.546 |
| HR (pbm) | 62.00 [50.00–74.00] | 65.00 [62.00–70.00] | 62.00 [60.00–74.00] | 72.00 [68.00–83.00] | 0.124 | 0.062 | 0.273 |
Data are presented as median and interquartile range in square brackets [IQR] for continuous variables. Bpm, beats per minute; IP, inpatient care; HLCT, high-level care treatment. The Mann–Whitney test was used to compare continuous variables between the groups at T0. No difference was found. The Wilcoxon test was performed to investigate intragroup changes between T0 and T1. Statistical significance for p < 0.05.
*
p < 0.05,
**
p < 0.01,
***
p < 0.001. Effect size (r) was calculated for the Mann–Whitney testa and the Wilcoxon testb. Small, medium, and large effects for r < 0.3, 0.3 ≤ r < 0.5 and r ≥ 0.5, respectively.